# CUMBERLAND PHARMACEUTICALS INC > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:b1879337-3bfd-4ab4-8159-762d72ab4598 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/cumberland-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 18 | | Claims under review | 1 | | Evidence records | 3 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-15T04:46:46.95181+00:00 | | Last reviewed | 2026-10-15T04:46:46.95181+00:00 | ## Identity - Legal name: CUMBERLAND PHARMACEUTICALS INC - Display name: CUMBERLAND PHARMACEUTICALS INC ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-15T20:00:57.275693+00:00 | | Completeness | 0.364 | | Record Quality | 0.833 | | Directors | 7 | | Committees | 4 | | Governance events | 13 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | NOT_REVIEWED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - A.J. Kazimi: Director. Status: current. Independent: false. Since: 1999-01-01. claim_id=alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:5 - Caroline R. Young: Director. Status: current. Independent: true. Since: 2016-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:6 - Gordon R. Bernard: Director. Status: current. Independent: true. Since: 2010-01-01. Committees: Compensation (chair); Compensation · Chair (member). claim_id=alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:7 - James R. Jones: Director. Status: current. Independent: true. Since: 2010-01-01. Committees: Audit (member). claim_id=alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:8 - Joseph C. Galante: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:9 - Kenneth J. Krogulski: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Audit (member). claim_id=alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:10 - Martin S. Brown, Jr.: Director. Status: current. Independent: true. Since: 2022-01-01. claim_id=alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:11 ## Committees - Audit (audit). Chair: Joseph C. Galante. Members: Joseph C. Galante (chair, current); James R. Jones (member, current); Kenneth J. Krogulski (member, current). committee_id=alpha:committee:cumberland-pharmaceuticals-inc:audit - Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Joseph C. Galante (member, current). committee_id=alpha:committee:cumberland-pharmaceuticals-inc:audit-chair - Compensation (compensation). Chair: Gordon R. Bernard. Members: Gordon R. Bernard (chair, current); Caroline R. Young (member, current). committee_id=alpha:committee:cumberland-pharmaceuticals-inc:compensation - Compensation · Chair (compensation). Chair: NOT_PUBLISHED. Members: Gordon R. Bernard (member, current). committee_id=alpha:committee:cumberland-pharmaceuticals-inc:compensation-chair ## Governance events - DIRECTOR_APPOINTED: Martin S. Brown, Jr. seat on CUMBERLAND PHARMACEUTICALS INC, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-15T04:46:46.95181+00:00. event_id=alpha:event:transition:1ely6ok1h72a1c - DIRECTOR_APPOINTED: Joseph C. Galante seat on CUMBERLAND PHARMACEUTICALS INC, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-15T04:46:46.95181+00:00. event_id=alpha:event:transition:1rsict81nxnfbs - COMMITTEE_CREATED: Audit · Chair committee of CUMBERLAND PHARMACEUTICALS INC, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-15T04:46:46.95181+00:00. event_id=alpha:event:transition:15ola4eywi0fo - COMMITTEE_MEMBER_ADDED: Joseph C. Galante member of Audit · Chair, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-15T04:46:46.95181+00:00. event_id=alpha:event:transition:kl7n4e18b2a4e - DIRECTOR_APPOINTED: Kenneth J. Krogulski seat on CUMBERLAND PHARMACEUTICALS INC, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-15T04:46:46.95181+00:00. event_id=alpha:event:transition:y33lktye3b97 - DIRECTOR_APPOINTED: Caroline R. Young seat on CUMBERLAND PHARMACEUTICALS INC, effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-15T04:46:46.95181+00:00. event_id=alpha:event:transition:1xi066rp0fmfh - COMMITTEE_MEMBER_ADDED: Caroline R. Young member of Compensation, effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-15T04:46:46.95181+00:00. event_id=alpha:event:transition:ly31w2ua8ut0 - DIRECTOR_APPOINTED: Gordon R. Bernard seat on CUMBERLAND PHARMACEUTICALS INC, effective 2010-01-01. Effective: 2010-01-01. Detected: 2026-10-15T04:46:46.95181+00:00. event_id=alpha:event:transition:18k36m2uc31jq - DIRECTOR_APPOINTED: James R. Jones seat on CUMBERLAND PHARMACEUTICALS INC, effective 2010-01-01. Effective: 2010-01-01. Detected: 2026-10-15T04:46:46.95181+00:00. event_id=alpha:event:transition:145vxpjobwud1 - COMMITTEE_MEMBER_ADDED: James R. Jones member of Audit, effective 2010-01-01. Effective: 2010-01-01. Detected: 2026-10-15T04:46:46.95181+00:00. event_id=alpha:event:transition:mwfpbxrc3syv - COMMITTEE_CREATED: Compensation · Chair committee of CUMBERLAND PHARMACEUTICALS INC, effective 2010-01-01. Effective: 2010-01-01. Detected: 2026-10-15T04:46:46.95181+00:00. event_id=alpha:event:transition:120nl4415qkotm - COMMITTEE_MEMBER_ADDED: Gordon R. Bernard member of Compensation · Chair, effective 2010-01-01. Effective: 2010-01-01. Detected: 2026-10-15T04:46:46.95181+00:00. event_id=alpha:event:transition:trerqn1a378r1 - DIRECTOR_APPOINTED: A.J. Kazimi seat on CUMBERLAND PHARMACEUTICALS INC, effective 1999-01-01. Effective: 1999-01-01. Detected: 2026-10-15T04:46:46.95181+00:00. event_id=alpha:event:transition:17c8wl51ak1mtv ## Scoped resources - `alpha://company/cumberland-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record - `alpha://company/cumberland-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/cumberland-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/cumberland-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=board - `alpha://company/cumberland-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/cumberland-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/cumberland-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/cumberland-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/cumberland-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/cumberland-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/cumberland-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/cumberland-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/cumberland-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/cumberland-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/cumberland-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/cumberland-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/cumberland-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/cumberland-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/cumberland-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/cumberland-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=events - `alpha://company/cumberland-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/cumberland-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/cumberland-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:committee_appointment:13: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:joseph-c-galante","name":"Joseph C. Galante"},"source_id":"board_seats"}` - Claim alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:james-r-jones","name":"James R. Jones"},"source_id":"board_seats"}` - Claim alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:kenneth-j-krogulski","name":"Kenneth J. Krogulski"},"source_id":"board_seats"}` - Claim alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:gordon-r-bernard","name":"Gordon R. Bernard"},"source_id":"board_seats"}` - Claim alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:caroline-r-young","name":"Caroline R. Young"},"source_id":"board_seats"}` ## Leadership - A.J. Kazimi: Director. Claim: alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:5. Valid from: 1999-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc. - Caroline R. Young: Director, Compensation. Claim: alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:6. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc. - Gordon R. Bernard: Director, Compensation · Chair. Claim: alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:7. Valid from: 2010-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc. - James R. Jones: Director, Audit. Claim: alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:8. Valid from: 2010-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc. - Joseph C. Galante: Director, Audit · Chair. Claim: alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:9. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc. - Kenneth J. Krogulski: Director, Audit. Claim: alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:10. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc. - Martin S. Brown, Jr.: Director. Claim: alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:11. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Joseph C. Galante; Members Joseph C. Galante (Chair); James R. Jones; Kenneth J. Krogulski. Claim: alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:committee_record:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a27f02b8fd03147b524d801def20b71dc8d883cd06b8fa8ad7926d598f1f591b. - Compensation: Chair Gordon R. Bernard; Members Gordon R. Bernard (Chair); Caroline R. Young. Claim: alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a27f02b8fd03147b524d801def20b71dc8d883cd06b8fa8ad7926d598f1f591b. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - CUMBERLAND PHARMACEUTICALS INC. Claim: alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:565f1630e295cf65476aac2d3f39b4ccd87d7cc4b091865782b1a6ff0681077f. ## Entity Status - Public listing published. Claim: alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:565f1630e295cf65476aac2d3f39b4ccd87d7cc4b091865782b1a6ff0681077f. ## Published Fact - US. Claim: alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:565f1630e295cf65476aac2d3f39b4ccd87d7cc4b091865782b1a6ff0681077f. ## Committee Appointment - Joseph C. Galante: chair, Audit. Claim: alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:committee_appointment:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a27f02b8fd03147b524d801def20b71dc8d883cd06b8fa8ad7926d598f1f591b. - James R. Jones: member, Audit. Claim: alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a27f02b8fd03147b524d801def20b71dc8d883cd06b8fa8ad7926d598f1f591b. - Kenneth J. Krogulski: member, Audit. Claim: alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a27f02b8fd03147b524d801def20b71dc8d883cd06b8fa8ad7926d598f1f591b. - Gordon R. Bernard: chair, Compensation. Claim: alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a27f02b8fd03147b524d801def20b71dc8d883cd06b8fa8ad7926d598f1f591b. - Caroline R. Young: member, Compensation. Claim: alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a27f02b8fd03147b524d801def20b71dc8d883cd06b8fa8ad7926d598f1f591b. ## Security Listing - CPIX (NASDAQ). Claim: alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:security_listing:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:565f1630e295cf65476aac2d3f39b4ccd87d7cc4b091865782b1a6ff0681077f. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:565f1630e295cf65476aac2d3f39b4ccd87d7cc4b091865782b1a6ff0681077f: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc). - alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc: [CUMBERLAND PHARMACEUTICALS INC DEF 14A 2026-03-09](https://www.sec.gov/Archives/edgar/data/1087294/000108729426000025/cpix-20260309.htm). - alpha:projection-evidence:a27f02b8fd03147b524d801def20b71dc8d883cd06b8fa8ad7926d598f1f591b: [Audit](https://www.sec.gov/Archives/edgar/data/1087294/000108729426000025/cpix-20260309.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/cumberland-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/cumberland-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/cumberland-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-15T20:00:57.082284+00:00; recorded 2026-10-15T20:00:57.082284+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.